ALLIANCE's Pharma Model, a powerful
patient-based and disease-specific market model, the recommended framework for any patient/disease-based forecast
The pharma market model integrates data and intelligence from all
available internal and external sources into one comprehensive
and dynamic repository of drug, diagnosis and treatment specific
As the drug's market definition is patient-based , this model should
ideally form the corporate memory, the ‘one version of the
The market model is intuitive and easy to update, maintain or
refine on an ongoing basis and can be used on a national,
regional or international level. It accommodates up to 52
countries, with country-specific data gathering possibilities,
allowing free inputs for data
Impacts of any market update and any epidemiologic, treatment or
label changes are immediately accounted for.
This powerful model consists of a baseline and simulation part
so that for every variable what-if scenario’s can be played, and
their impact on patient potential can be assessed right away.
The design also makes it possible to compare the market
potential of a top-down approach with that of a bottom-up one.
Read more <